Decheng Capital China Life Sciences USD Fund III, Insider Profile
4 Followers
Decheng Capital China Life Sciences USD Fund III, , Ten Percent Owner at Alpine Immune Sciences, holds 4.48M shares in Beyondspring (Ticker: BYSI), holds 6.58M shares in Alpine Immune Sciences (Ticker: ALPN), holds 8.19M shares in Cue Health (Ticker: HLTHQ). Most recently, Decheng Capital China Life Sciences USD Fund III, Sold ― shares of Beyondspring on Aug 15, 2025 for an estimated value of $9.80K.
Decheng Capital China Life Sciences USD Fund III, insider profile FAQ
What is the percentage of profitable transactions made by Decheng Capital China Life Sciences USD Fund III, ?
The percentage of profitable transactions made by Decheng Capital China Life Sciences USD Fund III, is ―.
What is the average return per transaction made by Decheng Capital China Life Sciences USD Fund III, ?
The average return per transaction made by Decheng Capital China Life Sciences USD Fund III, is ―.
What stocks does Decheng Capital China Life Sciences USD Fund III, hold?
Decheng Capital China Life Sciences USD Fund III, holds: ALPN, HLTHQ, BYSI stocks.
What was Decheng Capital China Life Sciences USD Fund III, ’s latest transaction?
Decheng Capital China Life Sciences USD Fund III, latest transaction was an Informative Sell of $9.80K.
What was Decheng Capital China Life Sciences USD Fund III, 's most profitable transaction?
Decheng Capital China Life Sciences USD Fund III, ’s most profitable transaction was an Informative Buy of ALPN stock on September 21, 2021. The return on the trade was -28.40%.
What is Decheng Capital China Life Sciences USD Fund III, 's role in Alpine Immune Sciences?
Decheng Capital China Life Sciences USD Fund III, 's role in Alpine Immune Sciences is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.